SCHEMBL16701247

SCHEMBL16701247

NC(=O)c1nc(Nc2ccc3ccc(F)cc3c2)sc1NC(=O)c1ccc(CN2CCOCC2)cc1

nearest known ligand 0.83

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TNIK Q9UKE5 19/20 0.83
TBK1 Q9UHD2 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16701228 0.98 TNIK (0.85) TNIKTBK1
SCHEMBL16700160 0.91 TNIK (1.00) TNIK
SCHEMBL16699189 0.89 TNIK (0.86) TNIKTBK1
SCHEMBL16698949 0.86 TNIK (0.82) TNIKTBK1
SCHEMBL3397687 0.84 TBK1 (0.77) TNIKTBK1
SCHEMBL16699937 0.84 TNIK (0.91) TNIK
SCHEMBL16700420 0.83 TNIK (1.00) TNIK
SCHEMBL16699609 0.83 TNIK (0.85) TNIK
SCHEMBL16699335 0.82 TNIK (0.83) TNIK
SCHEMBL16698992 0.82 TNIK (0.79) TNIK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2855470-B1 NOVEL BICYCLIC THIAZOLE COMPOUNDS CARNA BIOSCIENCES INC (JP) 2018-10-17 EP disclosed
US-9102637-B2 Bicyclic thiazole compounds CARNA BIOSCIENCES, INC. (JP) 2015-08-11 US disclosed
US-9102637-B2 Bicyclic thiazole compounds CARNA BIOSCIENCES, INC. (JP) 2015-08-11 US disclosed
US-9102637-B2 Bicyclic thiazole compounds CARNA BIOSCIENCES, INC. (JP) 2015-08-11 US disclosed
US-20150133656-A1 NOVEL BICYCLIC THIAZOLE COMPOUNDS CARNA BIOSCIENCES INC. (JP) 2015-05-14 US disclosed
US-20150133656-A1 NOVEL BICYCLIC THIAZOLE COMPOUNDS CARNA BIOSCIENCES INC. (JP) 2015-05-14 US disclosed
US-20150133656-A1 NOVEL BICYCLIC THIAZOLE COMPOUNDS CARNA BIOSCIENCES INC. (JP) 2015-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150133656-A1 NOVEL BICYCLIC THIAZOLE COMPOUNDS TNIK, TNNI3K, TNK1 TNIK 1/4885TBK1 31/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.